Evidence map›Paper›PMID 29915352›Full record

ArticleNature communications2018

The Wave2 scaffold Hem-1 is required for transition of fetal liver hematopoiesis to bone marrow.

Lijian Shao, Jianhui Chang, Wei Feng, Xiaoyan Wang, Elizabeth A Williamson, Ying Li, Amir Schajnovitz, David Scadden, Luke J Mortensen, Charles P Lin and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. CRISPR/CAS9-mediated knockout of Abi1 inhibits p185Journal of hematology & oncology · 2020
    Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 1 country.

Lijian ShaoDepartment of Pharmacology, University of Illinois Chicago, Chicago, IL, 60612, USA.
Jianhui ChangDepartment of Pharmaceutical Sciences and Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Wei FengDepartment of Pharmaceutical Sciences and Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Xiaoyan WangDepartment of Pharmaceutical Sciences and Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Elizabeth A WilliamsonDepartment of Medicine and Pathology, University of Florida, Gainesville, FL, 32610, USA.
Ying LiDepartment of Medicine and Pathology, University of Florida, Gainesville, FL, 32610, USA.
Amir SchajnovitzStem Cell and Regenerative Biology Department, Harvard University, Cambridge, 02138, MA, USA.
David ScaddenStem Cell and Regenerative Biology Department, Harvard University, Cambridge, 02138, MA, USA.
Luke J MortensenRegenerative Medicine Center, University of Georgia, Athens, GA, 30602, USA.ORCID http://orcid.org/0000-0002-4331-4099
Charles P LinWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Linheng LiDepartment of Pathology and Laboratory, Medicine University of Kansas, Kansas City, 66160, KA, USA.ORCID http://orcid.org/0000-0001-9963-430X
Ariel PaulsonDepartment of Pathology and Laboratory, Medicine University of Kansas, Kansas City, 66160, KA, USA.
James DowningDepartment of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Daohong ZhouDepartment of Pharmaceutical Sciences and Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. zhoudaohong@cop.ufl.edu.
Robert A HromasOffice of the Dean and the Cancer Center, Long School of Medicine, University of Texas Health Science Center, San Antonio, TX, 78229, USA. hromas@uthscsa.edu.
Harvard University · USUniversity of Arkansas for Medical Sciences · USUniversity of Florida · USSt. Jude Children's Research Hospital · USStowers Institute for Medical Research · USThe University of Texas Health Science Center at San Antonio · USUniversity of Georgia · USUniversity of Illinois Chicago · USUniversity of Kansas · US

Funding

Transcriptional and epigenetic heterogeneity of stem/progenitor cellsP01HL131477 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI DANIEL G TENEN · 2017 to 2026
$24.6M
The Role o f Tetrahydrobiopterin (BH4) Bioavailability in Radiation-induced Skin InjuryP20GM109005 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI BOERMA, MARJAN · 2015 to 2024
$21.1M
EEPD1 Repair of Stressed Replication ForksR01CA205224 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robert A Hromas · 2016 to 2026
$3.3M
Cancer Therapy-induced Long-term Bone Marrow InjuryR01CA122023 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ZHOU, DAOHONG · 2007 to 2018
$3.1M
Ionizing radiation induced hematological malignanciesR01CA211963 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ZHOU, DAOHONG · 2017 to 2021
$1.8M
EPIGENETIC CONTROL OF NHEJ DNA REPAIRR01CA139429 · NCI · UNIVERSITY OF NEW MEXICO · PI HROMAS, ROBERT A · 2010 to 2014
$1.5M
Mechanisms for Chromosomal TranslocationsR01GM109645 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HROMAS, ROBERT A · 2015 to 2018
$1.2M
NCI NIH HHS R01 CA122023NCI NIH HHS R01 CA139429NCI NIH HHS R01 CA205224NCI NIH HHS R01 CA211963NHLBI NIH HHS P01 HL131477NIGMS NIH HHS R01 GM109645U.S. Department of Health & Human Services | National Institutes of Health (NIH) AI080421U.S. Department of Health & Human Services | National Institutes of Health (NIH) CA122023U.S. Department of Health & Human Services | National Institutes of Health (NIH) CA139429U.S. Department of Health & Human Services | National Institutes of Health (NIH) GM109645U.S. Department of Health & Human Services | National Institutes of Health (NIH) P20GM109005
6 · The paper itself

Abstract

The transition of hematopoiesis from the fetal liver (FL) to the bone marrow (BM) is incompletely characterized. We demonstrate that the Wiskott-Aldrich syndrome verprolin-homologous protein (WAVE) complex 2 is required for this transition, as complex degradation via deletion of its scaffold Hem-1 causes the premature exhaustion of neonatal BM hematopoietic stem cells (HSCs). This exhaustion of BM HSC is due to the failure of BM engraftment of Hem-1

Indexed as

HematopoiesisAdaptor Proteins, Signal TransducingAnimalsBone MarrowCell MovementCytoskeletal ProteinsFetal DevelopmentHematopoietic Stem CellsLiverMaleMice, Inbred C57BLMice, TransgenicProto-Oncogene Proteins c-ablWiskott-Aldrich Syndrome Protein FamilyAbi1 protein, mouseAdaptor Proteins, Signal TransducingCytoskeletal ProteinsHem1 protein, mouseProto-Oncogene Proteins c-ablWasf2 protein, mouseWiskott-Aldrich Syndrome Protein Family

Identifiers

PMID29915352
PMCPMC6006146
OpenAlexW2808234044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.